Learning Objectives:
At the conclusion of this activity, attendees should be able to:
- Outline the three types of medical countermeasures
- Describe the three key initial shelter and evacuation messages
- Provide resources to support radiation readiness
- Identify best practices for decontamination
- List potential routes of exposure
Presented By:
 Laura Anderko, PhD, RN Director, Mid-Atlantic Center for Children's Health and the Environment
Georgetown University
Region 3 PEHSU
 Jennifer Buzzell, MS Physical Scientist, Radiation Studies Section
Emergency Management, Radiation and Chemical Branch, CDC
|
Learning Objectives
At the conclusion of this activity, attendees should be able to:
- Describe what radon is and where it can be found
- Describe some of the known and hypothesized health risks associated with radon exposure
- Know the EPA action level for radon
- Examine some literature investigating whether there is evidence that radon increases the risk of developing lung cancer, leukemia, lymphoma, and CNS malignancies
- Apply this information to discussing radon mitigation with patients and with the community
Articles to be discussed:
- Erin C Peckham, M. E. S. H. E. D. J. L. P. H. L. P. J. L. (2015). Residential Radon Exposure and Incidence of Childhood Lymphoma in Texas, 1995–2011, 1–17. http://doi.org/10.3390/ijerph121012110
- Sheen, S., Lee, K. S., Chung, W. Y., Nam, S., & Kang, D. R. (2016). An updated review of case–control studies of lung cancer and indoor radon-Is indoor radon the risk factor for lung cancer? Annals of Occupational and Environmental Medicine, 1–9. http://doi.org/10.1186/s40557-016-0094-3
- Ou, J. Y., Fowler, B., Ding, Q., Kirchhoff, A. C., Pappas, L., Boucher, K., et al. (2018). A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population, 1–8. http://doi.org/10.1186/s12885-018-4002-9
- Del Risco Kollerud, R., Blaasaas, K. G., & Claussen, B. (2014). Risk of leukaemia or cancer in the central nervous system among children living in an area with high indoor radon concentrations: results from a cohort study in Norway. British Journal of Cancer, 111(7), 1413–1420. http://doi.org/10.1038/bjc.2014.400
Presented by:
 Keith Baker, MD Medical Toxicology Fellow
Rocky Mountain Poison and Drug Center
Denver, CO
Region 8 PEHSU
 Nick Brandehoff, MD
Medical Toxicology Fellow
Rocky Mountain Poison and Drug Center
Denver, CO
Region 8 PEHSU
|
Learning Objectives:
By the end of this module, participants should be able to:
- Identify the most common cancer risks after a nuclear power plant radionuclide release.
- Describe the importance of latency in the evaluation of cancer risk from environmental sources.
- Identify other non-cancer adverse outcomes in children following radionuclide releases.
Presented By:
Stephen W. Borron, MD, FACMT
Medical Director, West Texas Regional Poison Center
Director and Chief Medical Consultant, Southwestern Center for Pediatric Environmental Health
Texas Tech University Health Sciences Center
El Paso, TX
Region 6 PEHSU
|
Grand Rounds: Radiation Readiness - March 20, 2019 posted on Mar 16, 2020
